A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

T Kühr; S Burgstaller; Ute Apfelbeck; Werner Linkesch; H Seewann; M Fridrik; G Michlmayr; O Krieger; D Lutz; W Lin; J Pont; L Köck; K Abbrederis; C Baldinger; R Buder; D Geissler; H Hausmaninger; A Lang; A Zabernigg; C Duba; W Hilbe; W Eisterer; M Fiegl; R Greil; G Gastl; J Thaler; Austrian CML Study Group

doi:10.1016%2FS0145-2126%2802%2900223-0

A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

T Kühr
, S Burgstaller
, Ute Apfelbeck
, Werner Linkesch
, H Seewann
, M Fridrik
, G Michlmayr
, O Krieger
, D Lutz
, W Lin
, J Pont
, L Köck
, K Abbrederis
, C Baldinger
, R Buder
, D Geissler
, H Hausmaninger
, A Lang
, A Zabernigg
, C Duba

W Hilbe, W Eisterer, M Fiegl, R Greil, G Gastl, J Thaler, Austrian CML Study Group

Department of Internal Medicine

Research output: Contribution to journal › Research article

15 Citations (Web of Science)

Original language	English
Journal	Leukemia Research
DOIs	https://doi.org/10.1016%2FS0145-2126%2802%2900223-0
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

302 Clinical Medicine

DOI

10.1016%2FS0145-2126%2802%2900223-0

Links

Cite this

Kühr, T., Burgstaller, S., Apfelbeck, U., Linkesch, W., Seewann, H., Fridrik, M., Michlmayr, G., Krieger, O., Lutz, D., Lin, W., Pont, J., Köck, L., Abbrederis, K., Baldinger, C., Buder, R., Geissler, D., Hausmaninger, H., Lang, A., Zabernigg, A., ... Austrian CML Study Group (2003). A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML). Leukemia Research. https://doi.org/10.1016%2FS0145-2126%2802%2900223-0

@article{2131a9835d894fd686c754802b6f972a,

title = "A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).",

author = "T K{\"u}hr and S Burgstaller and Ute Apfelbeck and Werner Linkesch and H Seewann and M Fridrik and G Michlmayr and O Krieger and D Lutz and W Lin and J Pont and L K{\"o}ck and K Abbrederis and C Baldinger and R Buder and D Geissler and H Hausmaninger and A Lang and A Zabernigg and C Duba and W Hilbe and W Eisterer and M Fiegl and R Greil and G Gastl and J Thaler and \{Austrian CML Study Group\}",

year = "2003",

doi = "10.1016\%2FS0145-2126\%2802\%2900223-0",

language = "English",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

}

Kühr, T, Burgstaller, S, Apfelbeck, U, Linkesch, W, Seewann, H, Fridrik, M, Michlmayr, G, Krieger, O, Lutz, D, Lin, W, Pont, J, Köck, L, Abbrederis, K, Baldinger, C, Buder, R, Geissler, D, Hausmaninger, H, Lang, A, Zabernigg, A, Duba, C, Hilbe, W, Eisterer, W, Fiegl, M, Greil, R, Gastl, G, Thaler, J & Austrian CML Study Group 2003, 'A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).', Leukemia Research. https://doi.org/10.1016%2FS0145-2126%2802%2900223-0

TY - JOUR

T1 - A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

AU - Kühr, T

AU - Burgstaller, S

AU - Apfelbeck, Ute

AU - Linkesch, Werner

AU - Seewann, H

AU - Fridrik, M

AU - Michlmayr, G

AU - Krieger, O

AU - Lutz, D

AU - Lin, W

AU - Pont, J

AU - Köck, L

AU - Abbrederis, K

AU - Baldinger, C

AU - Buder, R

AU - Geissler, D

AU - Hausmaninger, H

AU - Lang, A

AU - Zabernigg, A

AU - Duba, C

AU - Hilbe, W

AU - Eisterer, W

AU - Fiegl, M

AU - Greil, R

AU - Gastl, G

AU - Thaler, J

AU - Austrian CML Study Group

PY - 2003

Y1 - 2003

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000181622800006

UR - https://pubmed.ncbi.nlm.nih.gov/12620292

U2 - 10.1016%2FS0145-2126%2802%2900223-0

DO - 10.1016%2FS0145-2126%2802%2900223-0

M3 - Research article

C2 - 12620292

SN - 0145-2126

JO - Leukemia Research

JF - Leukemia Research

ER -